Abstract P6-10-03: Germline (g)BRCA1/2 mutations (m) and hematological toxicities in patients (pts) with triple negative breast cancer (TNBC) treated with neoadjuvant chemotherapy (NACT)
Year: 2020
Type: conference-abstract
Source: Cancer Research
Authors: Jenny Furlanetto, Volker Möbus, Andreas Schneeweiss, Kerstin Rhiem, Hans Tesch, Jens-Uwe Blohmer, Kristina Lübbe, Michael Untch, Christoph Salat, Jens Huober, Peter Klare, Rita Schmutzler, Fergus J Couch, Bianca Lederer, Bernd Gerber, Dirk-Michael Zahm, Ingo Bauerfeind, Valentina Nekljudova, Claus Hanusch, Christian Jackisch, Theresa Link, Sibylle Loibl, Peter A Fasching
Institutions: German Breast Group, Klinikum Frankfurt Höchst, National Center for Tumor Diseases, Charité – Universitätsmedizin Berlin, Diakovere, Helios Hospital Berlin-Buch, Universität Ulm, University Hospital Ulm, Mayo Clinic, Klinikum Südstadt Rostock, SRH Wald-Klinikum Gera, Rotkreuzklinikum München, Sana Klinikum Offenbach, University Hospital Carl Gustav Carus, Technische Universität Dresden, Universitätsklinikum Erlangen, Comprehensive Cancer Center Erlangen
Language: English
Subfield: Genetics
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W3006185007